retatrutide safe to use Promises Big Weight Loss, but Safety Remains a Question Use of an unapproved triple-hormone

This was demonstrated in two randomised controlled trials (RCTs) that showed a decrease in epicardial adipose tissue in patients with T2D and obesity on liraglutide and exenatide according to echocardiography and cardiac MRI

Tirzepatide targets both the GLP-1 receptor and the GIP receptor another hormone involved in metabolism

In an ever-evolving skincare landscape, liposomal technology is driving a seismic shift in the way ingredients are delivered, setting a new gold standard in performance and effectiveness

These benefits persisted after adjusting for multiple potential confounders including baseline liver disease severity, comorbidities, and use of other medications [55]